PRODUCT INDICATIONS AND USE
Adult and pediatric patients 12 years of age and older:
Adult and pediatric patients 12 years of age and older: Intra-arterial digital subtraction angiography (270 and 320 mg iodine/mL); angiocardiography (left ventriculography and selective coronary arteriography), peripheral arteriography, visceral arteriography, and cerebral arteriography (320 mg iodine/mL). Pediatric patients less than 12 years of age: Angiocardiography, cerebral arteriography, and visceral arteriography (320 mg iodine/mL)
Computed tomography (CT) imaging of the head and body (270 and 320 mg iodine/mL) and excretory urography (270 and 320 mg iodine/mL); peripheral venography (270 mg iodine/mL); coronary computed tomography angiography (CCTA) to assist in the diagnostic evaluation of patients with suspected coronary artery disease (320 mg iodine/mL). Pediatric patients less than 12 years of age:
CT imaging of the head and body (270 mg iodine/mL) and excretory urography (270 mg iodine/mL).
IMPORTANT SAFETY INFORMATION
WARNING: NOT FOR INTRATHECAL USE
See full Prescribing Information for complete Boxed Warning.
Inadvertent intrathecal administration may cause death, convulsions/seizures, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, rhabdomyolysis, hyperthermia, and brain edema.
Please see Indications and additional Important Safety Information about Visipaque at the bottom of this page. Please also read the full Prescribing Information.
Visipaque is an intravascular contrast media solution, manufactured by GE Healthcare, indicated for use in computed tomography (CT) and X-ray scans in different, approved clinical settings.
Visipaque is a dimeric, isosmolar, nonionic, water-soluble, radiographic contrast agent made with iodixanol. Visipaque is provided as a sterile, pyrogen-free, colorless to pale yellow solution, in concentrations of 270 and 320 mg of organically bound iodine per mL (550 and 652 mg of iodixanol per mL, respectively).